Table 2 Participant characteristics (n = 1597)
From: Validity assessment of the PROMIS fatigue domain among people living with HIV
Characteristic | N | Percent | Recent CD4Â <500 | Recent CD4 500+ | ||
|---|---|---|---|---|---|---|
N | Percent | N | Percent | |||
Male | 1315 | 82.3 | 591 | 84.8 | 724 | 80.4 |
Race | ||||||
 White | 861 | 53.9 | 346 | 49.6 | 515 | 57.2 |
 Black | 461 | 28.9 | 197 | 28.3 | 264 | 29.3 |
 Hispanic | 195 | 12.2 | 105 | 15.1 | 90 | 10.0 |
 Other | 80 | 5.0 | 49 | 7.0 | 31 | 3.4 |
HIV Symptom Index fatigue item | ||||||
 No fatigue | 558 | 34.9 | 233 | 33.4 | 325 | 36.1 |
 Doesn’t bother me | 151 | 9.5 | 66 | 9.5 | 85 | 9.4 |
 Bothers me a little | 383 | 24.0 | 161 | 23.1 | 222 | 24.7 |
 Bothers me | 260 | 16.3 | 117 | 16.8 | 143 | 15.9 |
 Bothers me a lot | 221 | 13.8 | 110 | 15.8 | 111 | 12.3 |
 Did not answer | 24 | 1.5 | 10 | 1.4 | 14 | 1.6 |
CD4 Nadir | ||||||
 <200 | 732 | 45.8 | 487 | 69.9 | 245 | 27.2 |
 200 to <350 | 392 | 24.6 | 152 | 21.8 | 240 | 26.7 |
 350 or higher | 468 | 29.3 | 55 | 7.9 | 413 | 45.9 |
 Missing | 5 | 0.3 | 3 | 0.4 | 2 | 0.2 |
Taking anti-HIV meds | 1412 | 88.4 | 604 | 86.7 | 808 | 89.8 |